Search - tctmd.com

Displaying 1 - 20 of 681

Sort: Relevancy | Date

News Conference News ISC 2026

FASTEST Hints at Benefits of Hemostatic Therapy for Acute ICH in Select Groups

Todd Neale

February 05, 2026

News Opinion CV Team Dispatch

January 2026 Dispatch for the CV Team

L.A. McKeown

January 16, 2026

News Daily News

FDA Approves Sapien M3 for Transseptal Mitral Valve Replacement

Michael O'Riordan

December 23, 2025

News Daily News

Remission From Prediabetes Halves CV Risk: Registry Data

Yael L. Maxwell

December 19, 2025

News Daily News

Pediatric Hypertension On the Rise Globally

Todd Neale

November 28, 2025

News Daily News

High Adolescent BP Tied to Subclinical Disease in Middle Age

Michael O'Riordan

November 20, 2025

News Conference News AHA 2025

Lower Mortality With Complete Revascularization in Acute MI Patients With MVD

Michael O'Riordan

November 12, 2025

News Conference News TCT 2025

ENCIRCLE: Good Results With Sapien M3 Transseptal TMVR

Todd Neale

October 27, 2025

Presentation TCT 2025

Commentary

Presenter: Jeffrey W. Moses

October 26, 2025

Presentation TCT 2025

A Randomized, Multicenter, Non-Inferiority Comparison of Intravascular Lithotripsy and Super-High-Pressure Non-Compliant Balloons for Treatment of Calcified and Refractory Coronary Lesions - The VICTORY Trial

Presenter: Matthias Bossard

October 26, 2025

Presentation TCT 2025

Commentary

Presenter: Antonio Colombo

October 26, 2025

Presentation TCT 2025

Randomized Comparison of Intravascular Lithotripsy vs. Cutting Balloon Treatment in Calcified Coronary Artery Disease – The Short-CUT Trial

Presenter: Suzanne J. Baron

October 26, 2025

Presentation TCT 2025

Commentary

Presenter: Robert A. Byrne

October 26, 2025

Presentation TCT 2025

Sirolimus-Eluting Balloon Versus Repeat Drug-Eluting Stenting or Balloon Angioplasty for In-stent Restenosis

Presenter: Donald Cutlip

October 26, 2025

Presentation TCT 2025

Commentary

Presenter: Fernando Alfonso

October 26, 2025

Presentation TCT 2025

One-Year Results of the SELUTION DeNovo Trial Comparing a Strategy of PCI with a Sirolimus-eluting Balloon and Provisional Stenting Versus Systematic DES Implantation to Treat DeNovo Coronary Lesions

Presenter: Christian M. Spaulding

October 26, 2025

News Daily News

Semaglutide’s CV Effects Only Partially Tied to Weight Loss: SELECT Analysis

Yael L. Maxwell

October 24, 2025

News Opinion Editor's Corner TCT 2025

What’s Going to Be Hot at TCT 2025

Michael O'Riordan

October 09, 2025

News Opinion CV Team Dispatch

September 2025 Dispatch for the CV Team

L.A. McKeown

September 30, 2025

News Conference News ESC 2025

Renewed Questions About Safety of Paclitaxel Devices in PAD: SWEDEPAD

L.A. McKeown

September 05, 2025

Advertisement

FASTEST Hints at Benefits of Hemostatic Therapy for Acute ICH in Select Groups

January 2026 Dispatch for the CV Team

FDA Approves Sapien M3 for Transseptal Mitral Valve Replacement

Remission From Prediabetes Halves CV Risk: Registry Data

Pediatric Hypertension On the Rise Globally

High Adolescent BP Tied to Subclinical Disease in Middle Age

Lower Mortality With Complete Revascularization in Acute MI Patients With MVD

ENCIRCLE: Good Results With Sapien M3 Transseptal TMVR

Commentary

A Randomized, Multicenter, Non-Inferiority Comparison of Intravascular Lithotripsy and Super-High-Pressure Non-Compliant Balloons for Treatment of Calcified and Refractory Coronary Lesions - The VICTORY Trial

Commentary

Randomized Comparison of Intravascular Lithotripsy vs. Cutting Balloon Treatment in Calcified Coronary Artery Disease – The Short-CUT Trial

Commentary

Sirolimus-Eluting Balloon Versus Repeat Drug-Eluting Stenting or Balloon Angioplasty for In-stent Restenosis

Commentary

One-Year Results of the SELUTION DeNovo Trial Comparing a Strategy of PCI with a Sirolimus-eluting Balloon and Provisional Stenting Versus Systematic DES Implantation to Treat DeNovo Coronary Lesions

Semaglutide’s CV Effects Only Partially Tied to Weight Loss: SELECT Analysis

What’s Going to Be Hot at TCT 2025

September 2025 Dispatch for the CV Team

Renewed Questions About Safety of Paclitaxel Devices in PAD: SWEDEPAD

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content